Helen Louise Collins

CHIEF MEDICAL OFFICER

Helen Louise Collins (CHIEF MEDICAL OFFICER) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.4M of ELVN (40,000 sh × $35.10, as filed), executed Mar 25.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.0M

shares × price, as filed

Last traded

Sep 17

Filed today

Median ADV $83.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

ELVN

Enliven Therapeutics, Inc. ELVN · 0 buys · 10 sells 10 filings

Recent filings

ELVNSALE Enliven Therapeutics, Inc. View filing → $146K
2,916 sh × $50.03
Exec Sep 17
Filed Sep 21 · 5:22 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $228K
3,900 sh × $58.37
Exec Aug 17
Filed Aug 19 · 4:16 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $225K
4,247 sh across 2 lots
Exec Jul 17
Filed Jul 21 · 5:23 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $114K
2,599 sh × $43.87
Exec Jun 17
Filed Jun 22 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $137K
3,475 sh × $39.53
Exec May 18
Filed May 20 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $232K
4,860 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $1.4M
40,000 sh × $35.10
Exec Mar 25
Filed Mar 27 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $139K
5,000 sh × $27.76
Exec Mar 17
Filed Mar 19 · 5:30 PM ET More filings →